Is This the Most Dangerous Health Care Dividend?

When looking for large health care dividends, investors are primarily limited to large pharma stocks. However, there are a few exceptions, including a brand new dividend payer in Questcor Pharmaceuticals (Nasdaq: QCOR  ) . Questcor isn't your run-of-the-mill defensive health care stock -- shares are dealing with multiple headwinds that could impact the sustainability of this payout in the long term.

In the following video, health care bureau chief Brenton Flynn outlines these headwinds, as well as his opinion on what type of investor should be looking to buy Questcor relative to a more stable big pharma dividend stock like Pfizer or Johnson & Johnson.

While you can certainly make huge gains in biotech and pharmaceuticals, the best investing approach is to choose great companies and stick with them for the long term. In our free report "3 Stocks That Will Help You Retire Rich," we name stocks that could help you build long-term wealth and retire well, along with some winning wealth-building strategies that every investor should be aware of. Click here now to keep reading.

Brenton Flynn has no positions in the stocks mentioned above. The Motley Fool has no positions in the stocks mentioned above. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.


Read/Post Comments (2) | Recommend This Article (1)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On October 18, 2012, at 8:03 PM, NotTheDroid wrote:

    Brenton,

    This was one of the best, balanced, reports that I have seen on Motley Fool, in quite a while.

    Some of the contributers attempt to sensationalize, instead of providing information.

    Thank you for a job well done!

  • Report this Comment On October 18, 2012, at 11:34 PM, JiminyBillyBob wrote:

    Brenton, I think you outlined everything well. I agree that with the recent drop in price, QCOR's risk/reward profile looks favorable. If everything is fine with the company, which there is more evidence to show that it is than not, this is one of those good opportunities.

    Carl

Add your comment.

DocumentId: 2064718, ~/Articles/ArticleHandler.aspx, 4/19/2014 12:55:12 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement